Results 11 to 20 of about 11,123,914 (335)
Teprotumumab for the Treatment of Active Thyroid Eye Disease.
New England Journal of Medicine, 2020 BACKGROUND Thyroid eye disease is a debilitating, disfiguring, and potentially blinding periocular condition for which no Food and Drug Administration-approved medical therapy is available.
Raymond S. Douglas +22 more
semanticscholar +1 more source
Formulation Considerations for the Management of Dry Eye Disease
Pharmaceutics, 2021 Dry eye disease (DED) is one of the most common ocular surface disorders characterised by a deficiency in quality and/or quantity of the tear fluid. Due to its multifactorial nature involving several inter-related underlying pathologies, it can rapidly ...
Priyanka Agarwal, J. Craig, I. Rupenthal
semanticscholar +1 more source
The Relationship Between Dry Eye Disease and Digital Screen Use
Clinical Ophthalmology, 2021 Dry eye disease is characterized by tear film instability that can result in ocular surface damage. Patients with dry eye disease may experience ocular pain/discomfort and visual disturbances that may negatively impact quality of life.
Z. Al-Mohtaseb +4 more
semanticscholar +1 more source
Alternative therapies for dry eye disease
Current Opinion in Ophthalmology, 2021 Purpose of review Dry eye disease (DED) is a multifactorial disease affecting approximately 5–50% of individuals in various populations. Contributors to DED include, but are not limited to, lacrimal gland hypofunction, meibomian gland dysfunction (MGD ...
Rhiya Mittal, Sneh N. Patel, A. Galor
semanticscholar +1 more source
Life, 2022 Thyroid eye disease (TED), an autoimmune inflammatory disorder of the orbit, presents with a potential array of clinical sequelae. The pathophysiology behind TED has been partially characterized in the literature. There remain certain elusive mechanisms welcoming of research advances.
Ramy Rashad +4 more
openaire +3 more sources
Ocular immunology and inflammation, 2021 Ocular allergy (OA) and dry eye disease (DED) are the most common ocular surface disorders with a potential severe impact on the patient’s quality of life. OA and DED may coexist and have a significant clinical overlap.
A. Leonardi, R. Modugno, Elena Salami
semanticscholar +1 more source
The eye in systemic disease [PDF]
South African Family Practice, 2014 The eye is a unique organ which is often involved in systemic disease. Patients with systemic disease may first present with eye pathology, and patients with known systemic illnesses may need to have their eyes specifically checked for ocular complications.
Lenake, M, Du Toit, N
openaire +4 more sources
Degraded reality: Using VR/AR to simulate visual impairments [PDF]
, 2018 The effects of eye disease cannot be depicted accurately using traditional media. Consequently, public understanding of eye disease is often poor. We present a VR/AR system for simulating common visual impairments, including disability glare, spatial ...
Jones, P. R., Ometto, G.
core +2 more sources
Sensory Compensation in Children Following Vision Loss after Trauma and Disease [PDF]
, 2015 Sensory compensation or sensory substitution occurs when a sense organ, such as the eye, is lost due to trauma or disease. Individuals often experience phantom limb sensation or pain but research increasingly points towards some individuals developing a ...
Chinnery, H., Thompson, S.
core +1 more source
Prevalence of thyroid eye disease in Graves’ disease: A meta‐analysis and systematic review
Clinical Endocrinology, 2020 Thyroid eye disease (TED) is a debilitating condition that frequently manifests in patients suffering from Graves’ disease (GD). This study aims to analyse the prevalence of TED among GD patients, with a focus on geographical region‐specific rates.
Y. Chin +7 more
semanticscholar +1 more source